Unitree Robotics (688836.SH), dubbed the "first humanoid robot stock," officially began trading on August 19, opening with a 629% surge at 1,100 yuan per share. The stock closed the day at 845 yuan, marking a 460.34% gain from its issue price. According to statistics compiled from the preliminary placement details for offline investors disclosed by Unitree Robotics, 37 insurance institutions collectively received approximately 6.83 million shares, with a total allocation value of nearly 1.03 billion yuan. This translates to a combined paper profit of 4.741 billion yuan for these insurers on the stock's debut day.
The top ten insurers by preliminary allocation volume posted a combined paper gain of 4.207 billion yuan on day one, while the remaining 27 insurers recorded a combined profit of 534 million yuan. Breaking this down, Taikang Asset, China Life Pension, Ping An Pension, Huatai Asset, Changjiang Pension, PICC Pension, Taiping Pension, Sunshine Life Asset Management, Ping An Asset, and Generali China Life Asset Management posted first-day paper gains of 1.263 billion yuan, 647 million yuan, 586 million yuan, 563 million yuan, 407 million yuan, 348 million yuan, 119 million yuan, 100 million yuan, 95 million yuan, and 79 million yuan, respectively.
Where the money came from
Prior to the IPO, insurers also gained indirect stakes in Unitree Robotics by acting as limited partners (LPs) in private equity funds managed by leading venture capital firms. For instance, CPIC Changhang Equity Investment Fund (Wuhan) Partnership, AIA Life, and MetLife Sino-US United entered through Matrix Partners China's third fund. Similarly, Ruize Zhongren Life, New China Life, and Zibai Insurance participated via Jinshi Growth Capital. China Post Life made its move through the China Internet Investment Fund. Unitree's prospectus reveals that Matrix Partners China's third fund counts three insurance investors among its partners: CPIC Changhang, AIA Life, and MetLife, holding 24.59%, 19.672%, and 9.836% stakes respectively. Wind data shows Ruize Zhongren Life, New China Life, and Zibai Property Insurance hold 5.45%, 2.55%, and 1% in Jinshi Growth. China Post Life is also a major shareholder of the China Internet Investment Fund with a 19.09% stake.
Public filings also show Ping An, as an LP, committed capital to both the Sequoia Capital China RMB VII Fund and the IDG Capital Beyond III Fund, with Sequoia China and IDG Capital serving as GPs to manage investment decisions and post-investment oversight, thereby gaining indirect exposure to Unitree. Before this offering, these funds held substantial positions in the company: Ningbo Sequoia held 22.6054 million shares, Jinshi Growth held 15.1142 million, China Internet Investment Fund held 7.6767 million, and Matrix Partners China's third fund held 4.3428 million.
Unitree's announcement shows the public offering comprised 40.4464 million shares, representing 10% of the post-issuance total share capital. The IPO is expected to raise approximately 6.099 billion yuan, with planned allocations of 2.022 billion yuan for the intelligent robot model R&D project, 1.11 billion yuan for robot body R&D, 445 million yuan for new intelligent robot product development, and 624 million yuan for the intelligent robot manufacturing base construction project.
Multiple routes of entry
While no insurers appear as direct pre-IPO shareholders, they have built indirect positions through layered investment structures. Industry analysts note that investing as LPs in private equity funds that subsequently back hard-tech firms allows insurers to leverage GP expertise while remaining compliant with regulatory investment requirements. In April 2025, the National Financial Regulatory Administration issued a notice adjusting equity asset allocation ratios for insurance funds, raising the maximum permitted investment in a single venture capital fund from 20% to 30%, encouraging greater allocation toward strategic emerging industries to support new quality productive forces.
Beyond LP commitments to VC funds, insurers also participate by establishing or co-founding dedicated equity funds. Their investment in ChangXin Memory Technologies illustrates this second approach. Prior to its listing, Hexie Health, China Life Investment, PICC Capital, Sunshine Life, China Post Life, and PICC Sci-Tech had acquired positions of 901 million, 476 million, 467 million, 225 million, 225 million, and 90 million shares, respectively. On ChangXin's debut day, several insurers disclosed their investment methods. PICC Capital described deploying a "two-tiered model combining equity plans with private equity funds over five years of deep cultivation," while China Post Life cited a "dual-driver model of direct investment plus fund investment for precise, systematic placement in the hard-tech arena." In July of this year, China Life's announcement of a 5 billion yuan addition to the semiconductor sector also reflected this direct-fund approach. Within that structure, China Life was the primary capital contributor at 4.999 billion yuan, establishing Tianjin Shenghe Xincheng Equity Investment Fund Partnership alongside its affiliate China Life Industrial Investment Management.
The two sides of the coin
Fixed-income assets have long served as the ballast in insurers' asset allocation. However, the past year or two has seen a notable shift. Data from the third quarter of 2025 showed the proportion of bond allocations in insurer portfolios declining for the first time since the regulator began publishing such data in the second quarter of 2022. By the end of the first quarter of this year, life and property insurers' combined equity holdings reached 3.837 trillion yuan, up 2.7% from the fourth quarter of 2025 and approaching the scale of actively managed equity funds. According to the National Financial Regulatory Administration's just-released second-quarter 2026 insurance fund usage report, the balance of insurance capital invested in stocks has grown by 365.9 billion yuan so far this year, with 263.4 billion yuan of that added in the second quarter alone.
In equity investment, insurers are progressively constructing portfolios that combine high-dividend stocks with hard-tech exposure. The wave of insurer stake-building in 2025 centered on high-yield names across banking, energy, and utilities for steady dividend income. This year, however, the emphasis has shifted toward larger-scale deployments via private equity LP commitments and strategic placement subscriptions, concentrating on hard-tech leaders like ChangXin Memory Technologies, which listed at the end of July, and the newly listed Unitree Robotics. This subtle pivot in insurance capital allocation reflects both a response to national strategic imperatives for technological innovation and the internal pressure to mitigate interest rate spread losses. While the debut-day paper gains from both ChangXin and Unitree have captured market attention, every coin has two sides. Successfully backing the right hard-tech companies demands considerable strategic vision and patience, and the exit cycles for such ventures tend to be lengthy. Balancing returns against risk remains a persistent challenge for insurers.